To include your compound in the COVID-19 Resource Center, submit it here.
X4 Pharmaceuticals Inc. (Cambridge, Mass.) raised $27 million in a series B round led
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury